Anti-Cancer Product Best 98% Paclitaxel/Taxol Powder 33069-62-4

China Anti-Cancer Product Best 98% Paclitaxel/Taxol Powder 33069-62-4, Find details about China Paclitaxel Powder, CAS 33069-62-4 from Anti-Cancer Product Best 98% Paclitaxel/Taxol Powder 33069-62-4

Basic Info.

Model NO.

PI-007

Molecular Weight

853.91

Grade

Phamaceutical Grade

Assay

HPLC 98%

Shelf Life

2 Years Properly Stored

Trademark

Transport Package

Foil Bag

Origin

China

HS Code

2937290090

Model NO.

PI-007

Molecular Weight

853.91

Grade

Phamaceutical Grade

Assay

HPLC 98%

Shelf Life

2 Years Properly Stored

Trademark

Transport Package

Foil Bag

Origin

China

HS Code

2937290090

Product Desciption

Product name:Paclitaxel CAS 33069-62-4

Product name	Taxol/Paclitaxel
Specification	98%, 99.6%
Molecular formula	C47H51NO14
Molecular weight	853.92
CAS No	33069-62-4
Origin	Yew Taxus plants dried roots, leaves and bark
Appearance	White crystalline powder
Related substances	≤ 2.0% of total related substances
Organic volatile impurities	Complies with United States Pharmacopeia (USP) and the Chinese Pharmacopoeia (CP) Organic volatile impurities requirements.
Specific rotation	[α ] 20 D = -49.0 ° ~ 55.0 ° (10mg/mL solution in methanol), anhydrous solvent dry product.
Moisture	≤ 4.0%
Residue on ignition	≤ 0.2%
Heavy metals	≤ 0.002%
Microbial limit	≤ 100cfu / g paclitaxel; Meet on Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella, Enterobacter sterility test requirements of people.

Description
Paclitaxe powder is a chemotherapy drug that is given as a treatment for some types of cancer. Paclitaxe powder is a mitotic inhibitor now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi's sarcoma. Paclitaxe is also used for the prevention of restenosis.

Function
1. Paclitaxe is a mitotic inhibitor drup used in the treatment of cancer.

2. Isolated the compound from the bark of the Pacific yew tree, Taxus brevifolia, and noted its antitumor activity in a broad range of rodent tumors.

3. Paclitaxe has since become an effective tool of doctors who treat patients with lung, ovarian, breast cancer, and advanced forms of Kaposi's sarcoma.